Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:12 PM
Ignite Modification Date:
2025-12-24 @ 1:12 PM
NCT ID:
NCT02341495
Eligibility Criteria:
Inclusion Criteria:
* 65 or older (must have reached 65th birthday)
* Morphologically confirmed diagnosis of AML, excluding AML-M3
* Must have a Zubrod performance status of 0-3
Exclusion Criteria:
* Patients with known HIV infection are excluded. If HIV infection is suspected based on clinical condition, testing may be performed at the discretion of treatment team, but is not mandated prior to enrollment.
* Patients with central nervous system involvement by AML are excluded
* Patients with history of an active cancer (except basal cell and squamous cell cancers of the skin) within the previous 2 years are excluded
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
65 Years
Maximum Age:
89 Years
Study:
NCT02341495
Study Brief:
Protocol Section:
NCT02341495